| Xeraph vs King | 18–18 | 50.00% |
| Xeraph vs Reina | 14–21 | 40.00% |
| Xeraph vs Yoshimitsu | 6–14 | 30.00% |
| Xeraph vs Clive | 10–9 | 52.63% |
| Xeraph vs Victor | 7–11 | 38.89% |
| Xeraph vs Jin | 6–11 | 35.29% |
| Xeraph vs Miary Zo | 6–11 | 35.29% |
| Xeraph vs Law | 8–7 | 53.33% |
| Xeraph vs Hwoarang | 7–8 | 46.67% |
| Xeraph vs Asuka | 6–8 | 42.86% |
| Xeraph vs Azucena | 8–6 | 57.14% |
| Xeraph vs Steve | 5–8 | 38.46% |
| Xeraph vs Lili | 4–7 | 36.36% |
| Xeraph vs Dragunov | 2–9 | 18.18% |
| Xeraph vs Bryan | 4–6 | 40.00% |
| Xeraph vs Kazuya | 4–6 | 40.00% |
| Xeraph vs Heihachi | 3–7 | 30.00% |
| Xeraph vs Lars | 4–5 | 44.44% |
| Xeraph vs Alisa | 6–2 | 75.00% |
| Xeraph vs Lee | 5–3 | 62.50% |
| Xeraph vs Panda | 5–2–1 | 71.43% |
| Xeraph vs Jun | 7–1 | 87.50% |
| Xeraph vs Kuma | 2–5 | 28.57% |
| Xeraph vs Fahkumram | 0–7 | 0.00% |
| Xeraph vs Devil Jin | 3–3 | 50.00% |
| Xeraph vs Claudio | 2–4 | 33.33% |
| Xeraph vs Leroy | 2–4 | 33.33% |
| Xeraph vs Nina | 0–5 | 0.00% |
| Xeraph vs Eddy | 1–4 | 20.00% |
| Xeraph vs Armor King | 3–2 | 60.00% |
| Xeraph vs Paul | 2–2 | 50.00% |
| Xeraph vs Lidia | 2–2 | 50.00% |
| Xeraph vs Zafina | 1–2 | 33.33% |
| Xeraph vs Anna | 1–2 | 33.33% |
| Xeraph vs Jack-8 | 0–2 | 0.00% |
| Xeraph vs Feng | 0–2 | 0.00% |
| Xeraph vs Leo | 0–2 | 0.00% |
| Xeraph vs Xiaoyu | 0–1 | 0.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.